NYU Langone Medical Center

Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR plus ), human epidermal growth factor 2-negative (HER2-) advanced breast cancer (ABC) treated with fulvestrant (FUL) (+) ribociclib (RIB) (2019) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Conference contribution THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al. Conference contribution Histone H3K27 acetylation precedes active transcription during zebrafish zygotic genome activation as revealed by live-cell analysis (2019) Sato Y, Hilbert L, Oda H, Wan Y, Heddleston JM, Chew TL, Zaburdaev V, et al. Journal article DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAIVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY (2019) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Assudani D, et al. Conference contribution Artificial intelligence in musculoskeletal imaging: Current status and future directions (2019) Gyftopoulos S, Lin D, Knoll F, Doshi AM, Rodrigues TC, Recht MP Journal article, Review article Joint Multi-anatomy Training of a Variational Network for Reconstruction of Accelerated Magnetic Resonance Image Acquisitions (2019) Johnson PM, Muckley MJ, Bruno M, Kobler E, Hammernik K, Pock T, Knoll F Conference contribution Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib plus fulvestrant: Results from MONALEESA-3 (2018) Fasching P, Esteva FJ, Pivot X, Nusch A, Beck JT, Chan A, Pieris-Gunatilaka A, et al. Conference contribution A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. (2018) Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, et al. Journal article Evaluation of SparseCT on patient data using realistic undersampling models (2018) Chen B, Muckley M, Sodickson A, O'Donnell T, Knoll F, Sodickson D, Otazo R Conference contribution Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 (2018) Slamon DJ, Neven P, Chia S, Fasching P, De Laurentiis M, Im SA, Petrakova K, et al. Journal article